| Income Statement |
| Total Revenue | 258.00M |
|
| Revenues (USD) | 258.00M |
| Cost of Revenue | 157.40M |
| Gross Profit | 100.60M |
| Operating Expenses | 135.20M |
| Research and Development Expense | 26.90M |
| Selling, General and Administrative Expense | 108.30M |
| Operating Income | -34.60M |
| Income Tax Expense | 1.20M |
| Net Income | -35.80M |
| Net Income Common Stock | -35.80M |
| Net Income Common Stock (USD) | -35.80M |
| Consolidated Income | -35.80M |
| Earnings per Basic Share | -0.47 |
| Earnings per Basic Share (USD) | -0.47 |
| Earnings per Diluted Share | -0.47 |
| Earning Before Interest & Taxes (EBIT) | -34.60M |
| Earning Before Interest & Taxes (USD) | -34.60M |
| Weighted Average Shares | 76.31M |
| Weighted Average Shares Diluted | 76.31M |
| Balance Sheet |
| Cash and Equivalents | 386.50M |
| Cash and Equivalents (USD) | 386.50M |
| Investments | 751.30M |
| Trade and Non-Trade Receivables | 594.60M |
| Property, Plant & Equipment Net | 16.70M |
| Total Assets | 1.96B |
| Total Debt | 179.60M |
| Total Liabilities | 1.44B |
| Accumulated Retained Earnings (Deficit) | -1.50B |
| Accumulated Other Comprehensive Income | 700.00K |
| Shareholders Equity | 518.00M |
| Shareholders Equity (USD) | 518.00M |
| Total Debt (USD) | 179.60M |
| Deferred Revenue | 647.50M |
| Goodwill and Intangible Assets | 27.10M |
| Trade and Non-Trade Payables | 23.50M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.70M |
| Net Cash Flow from Financing | 26.20M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.30M |
| Capital Expenditure | -3.50M |
| Issuance (Purchase) of Equity Shares | 4.70M |
| Issuance (Repayment) of Debt Securities | 21.50M |
| Net Cash Flow from Investing | -34.60M |
| Net Cash Flow - Investment Acquisitions and Disposals | -31.10M |
| Net Cash Flow from Operations | -600.00K |
| Effect of Exchange Rate Changes on Cash | -1.30M |
| Share Based Compensation | 21.20M |